|Series B, 4/11 |
Morningside Venture Investments
Quantum Pacific Capital
Indel Therapeutics Inc. is a Vancouverâ€based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficultâ€toâ€treat and hospitalâ€acquired infections. These programs are based on Indelâ€™s paradigmâ€changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.